Staar Surgical (STAA) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Staar Surgical (STAA) do?
Staar Surgical Co (STAA) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Manufactures implantable lenses that eye surgeons insert to correct nearsightedness and astigmatism without removing natural tissue. Produces specialized implantable lenses made from proprietary collagen material to correct refractive vision conditions. It is worth $1.26B on the market and sold $328.08M over the last year.
- Market cap
- $1.26B
- Annual sales
- $328.08M
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Brief updated
- Nov 19, 2026
Brands and businesses behind STAA
- EVO ICL: Sells implantable phakic contact lenses directly to ophthalmic surgeons and clinics for vision correction.
- Visian ICL: Provides implantable collamer lenses globally for correcting severe nearsightedness, farsightedness, and astigmatism.
- Collamer: Proprietary biocompatible collagen copolymer material used across all company manufactured implantable optical devices.
STAA’s flags, in plain English
Each flag is a number from Staar Surgical’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.
Stupid Cash
Can pay this year's bills 4.7 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Low debt
Low debt, only 9% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Wide Gross Margin
Gross margin of 71.3% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Heavily Shorted
12% of tradable shares are bet against (sold short). A large share of the stock has been borrowed and sold by traders betting it will fall. That can be a warning, and it can also push the price up fast if they rush to buy it back.
2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about STAA
How big is Staar Surgical?
Staar Surgical’s market cap is $1.26B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $328.08M: what customers paid the company over the last year, before any costs.
What could go wrong with STAA?
A major portion of sales comes from China, making operational revenue highly vulnerable to shifts in local consumer spending and regulatory policies. That is one risk on Staar Surgical’s card. Its first risk flag is Heavily Shorted, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Staar Surgical’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. STAA’s filings on SEC.gov. The Margin Monkey is research, not advice.
